Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Circulating Tumor DNA × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 3 Genitourinary 2 Gynecologic 1 Dermatologic 1

Conditions

Interventions

pembrolizumab 57 Nivolumab 52 Ipilimumab 28 Cyclophosphamide 19 Specimen Handling 16 Magnetic Resonance Spectroscopy 15 Biopsy 14 cemiplimab 13 fludarabine 12 Opdualag 12 Radiosurgery 11 relatlimab 10 Blood Specimen Collection 10 aldesleukin 8 Interleukin-2 8 binimetinib 7 Surgical Procedures, Operative 6 Paclitaxel 6 mogamulizumab 5 fludarabine phosphate 5 encorafenib 5 atezolizumab 5 Temozolomide 5 Standard of Care 5 Radiotherapy 5 Immunotherapy 5 Immunoglobulin G 5 CTLA-4 Antigen 5 Bevacizumab 5 tebentafusp 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05940311 2024-11-27

VerSiLiB

Regina Elena Cancer Institute

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡